Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2020-08-25 Regulatory Filings
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from Ipsen announcing that results from their Phase III trial (MOVE) for a drug treating Fibrodysplasia Ossificans Progressiva (FOP) will be presented at the 2020 ASBMR annual meeting. It details clinical trial outcomes, discusses regulatory intentions (FDA submission, EMA discussions), and provides company background. This format—a formal announcement of clinical data presentation and regulatory updates, rather than the full financial report (10-K) or a comprehensive quarterly report (IR)—is characteristic of an Earnings Release (ER) or a general announcement. Since it focuses heavily on clinical trial results and future regulatory steps, it aligns best with an Earnings Release (ER) which often includes key clinical/operational highlights, or potentially an Investor Presentation (IP) if it were structured as slides, but the text format strongly suggests a press release announcing results. Given the options, 'ER' (Earnings Release) is the closest fit for a major data announcement press release, although 'RPA' (Report Publication Announcement) is also plausible if this were just announcing the presentation itself. However, the depth of the data summary suggests it functions as the primary release of this information, making ER more appropriate than RPA, which usually just states a report is available. Since it is a press release announcing key data points, ER is selected.
2020-08-25 French
Inside Information / Other news releases
Transaction in Own Shares Classification · 1% confidence The document explicitly details a 'Disclosure of transactions in own shares' occurring between specific dates (10/08/2020 and 14/08/2020). It presents aggregated data on the volume and price of shares acquired by the issuer (IPSEN) on the market (XPAR). This content directly matches the definition for 'Transaction in Own Shares' (share repurchase/issuance), which corresponds to the filing code POS.
2020-08-18 English
Informations privilégiées / Autres communiqués
Transaction in Own Shares Classification · 1% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 10/08/2020 au 14/08/2020" (Declaration of transactions on own shares carried out from 10/08/2020 to 14/08/2020). The content is a table detailing the volume and price of shares transacted by the issuer (IPSEN) during that period. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The appropriate code is POS.
2020-08-18 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Share Issue/Capital Change Classification · 1% confidence The document is titled 'Monthly information regarding the total number of voting rights and total number of shares of the Company' and references Article 223-16 of the AMF General Regulations. It provides a monthly update on the total number of shares and voting rights as of July 31, 2020. This specific type of periodic disclosure regarding share capital structure and voting rights does not fit neatly into the primary categories like 10-K, ER, or IR. It is a specific regulatory disclosure. Since there is no dedicated code for 'Voting Rights/Share Capital Monthly Update', and it is a formal regulatory disclosure, the most appropriate fallback category is Regulatory Filings (RNS), as it is a mandatory, periodic regulatory announcement that doesn't match the definitions for DVA (which is for *results* of a vote) or SHA (which is for *changes* like splits/issues).
2020-08-17 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital), referencing Article 223-16 of the AMF General Regulation. It presents a table showing the total number of shares and voting rights as of July 31, 2020. This content directly relates to the structure of the share capital and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it is a mandatory disclosure regarding the capital base, or potentially a 'Regulatory Filing' (RNS) if a more specific category isn't available. However, since it explicitly details the total number of shares and voting rights, SHA is the most precise fit among the provided options, as it concerns the capital structure.
2020-08-17 French
Déclaration de participation
Director's Dealing Classification · 1% confidence The document is titled "Déclaration de participation" (Declaration of Participation) and details the shareholdings and voting rights of specific parties (Beech Tree, Henri Beaufour, Beaufour-Schwabe concert) in IPSEN SA following a corporate merger (fusion-absorption). It explicitly states that no thresholds were crossed, but it reports the current ownership structure. This type of filing, which reports changes in significant share ownership or control thresholds, aligns directly with the definition of Major Shareholding Notification (MRQ). It is not an earnings release (ER), a full annual report (10-K), or a proxy statement (PSI).
2020-08-13 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.